| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695518 | Gynecologic Oncology Reports | 2017 | 4 Pages |
Abstract
- Secondary, reversion mutations in BRCA genes can restore protein function.
- Reversion mutations can underlie resistance to therapies such as PARP inhibitors.
- Reversion mutations arise during the course of treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paul Mayor, Laurie M. Gay, Shashikant Lele, Julia A. Elvin,